2. 1.Tema y conceptos
-Tema: signos, síntomas y tratamiento del parkinson.
-Conceptos (lenguaje documental mediante tesauro)
Signos y síntomas (pathological conditions, signs and symptoms)
Tratamiento (therapy)
Parkinson (parkinson disease)
3. 2. Estrategia de búsqueda
Signs AND symptoms AND therapy AND
“parkinson disease”
8. 7. Ya podemos citar la bibliografía en formato
Vancouver:1. Shannon KM, Bennett Jr. JP, Friedman JH. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate
Parkinson’s disease. Neurology [Internet]. 1997;49(3):724–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0030869562&partnerID=40&md5=232f94aeb82655685ff1840c4ff56f39
2. Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE. Analysis of the clinical problems in parkinsonism and the complications of
long-term levodopa therapy. Neurology [Internet]. 1979;29(9):1253–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0018415901&partnerID=40&md5=14d2e890714e90e181ed216b11b417ba
3. Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, et al. Freezing of gait in PD: Prospective assessment in the DATATOP
cohort. Neurology [Internet]. 2001;56(12):1712–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0035954349&partnerID=40&md5=990dedaf11a82b722708663f08ef167b
4. Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Le Bas JF, et al. Opposite motor effects of pallidal stimulation in Parkinson’s
disease. Ann Neurol [Internet]. 1998;43(2):180–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0031935016&doi=10.1002%2Fana.410430208&partnerID=40&md5=fe39a9b0140d0d0b8ec5609f95ee195f
5. Olanow CW, Hauser RA, Gauguster L, Malapira T, Koller W, Hubble J, et al. The effect of deprenyl and levodopa on the progression of
Parkinson’s disease. Ann Neurol [Internet]. 1995;38(5):771–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0028858370&doi=10.1002%2Fana.410380512&partnerID=40&md5=ad900864a1447cd5c80c63eecd21396d
9. 6. Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B. Improvement of bilateral motor functions in patients with Parkinson
disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg [Internet]. 2005;102(2):216–
22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
14844311296&doi=10.3171%2Fjns.2005.102.2.0216&partnerID=40&md5=92d8ac768d37fb12c7dfab5261fb7e06
7. Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, et al. Unilateral transplantation of human fetal mesencephalic tissue
into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med [Internet]. 1992;327(22):1541–8. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026447667&partnerID=40&md5=b78dadeb9eceb2a475e87c65380cd481
8. Frith CD. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med
[Internet]. 1987;17(3):631–48. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-
0023636736&doi=10.1017%2FS0033291700025873&partnerID=40&md5=4e33000546a78c8d56f9b2993d847ce4
9. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and
subthalamic nuclei in severe Parkinson’s disease. Brain [Internet]. 2007;130(6):1596–607. Available from:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-
34250796156&doi=10.1093%2Fbrain%2Fawl346&partnerID=40&md5=e4839e92aec7a6702627be7627e22952
10. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas J-F, Perret JE, et al. Effect on parkinsonian signs and symptoms of bilateral
subthalamic nucleus stimulation. Lancet [Internet]. 1995;345(8942):91–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-
s2.0-0028796071&doi=10.1016%2FS0140-6736%2895%2990062-4&partnerID=40&md5=ff4a4d4912fa717db3d419b67bc7ebde
